Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
drugs
2
×
life sciences
alirocumab
alnylam pharmaceuticals
amgen
bioinnovation capital
biolabs
boston
chemotherapy
clinical trials
daraprim
drug pricing
epipen
epipens
evercore isi
evolocumab
exome
gene therapy
generic drugs
heart attack
inclisiran
insulin
johannes fruehauf
joseph swartz
labcentral
life science
martin shkreli
medicines co.
mylan
national blog main
national xcon
new york
new york blog main
new york top stories
novartis
oncology
pcsk9 inhibitors
peter kolchinsky
What
drug
2
×
long
2
×
alnylam
based
biotech
cholesterol
data
driving
evidence
good
healthcare
heart
history
improved
industry
innovation
innovations
investment
lasting
life
looms
lowering
medco
medical
medicines
new
outcomes
partner
pharmaceuticals
presented
pricing
proud
public
reckoning
rna
sciences
supporting
term
touts
use
Language
unset
Current search:
long
×
drug
×
drugs
×
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms